世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0275 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、アルツハイマー病治療・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腰椎穿刺検査、コンピューター断層撮影（CT）スキャン、磁気共鳴画像（MRI）、脳波（EEG）、ポジトロン放出断層撮影（PET）スキャン、その他）、用途別市場規模（市販薬、パイプライン薬）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・アルツハイマー病治療・診断の市場動向 ・企業の競争状況、市場シェア ・アルツハイマー病治療・診断の種類別市場規模（腰椎穿刺検査、コンピューター断層撮影（CT）スキャン、磁気共鳴画像（MRI）、脳波（EEG）、ポジトロン放出断層撮影（PET）スキャン、その他） ・アルツハイマー病治療・診断の用途別市場規模（市販薬、パイプライン薬） ・アルツハイマー病治療・診断の北米市場規模2016-2027（アメリカ、カナダ） ・アルツハイマー病治療・診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・アルツハイマー病治療・診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アルツハイマー病治療・診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・アルツハイマー病治療・診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Eisai、Novartis、Forest Laboratories、TauRx Therapeutics、AC Immune、Johnson & Johnson.、H. Lundbeck） ・結論

Alzheimers is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. Alzheimers is one of the leading causes of death in the United States, with more than 5 million Americans diagnosed with this dreaded disease, in year 2014.

Market Analysis and Insights: Global Alzheimer’s Disease Therapeutics and Diagnostics Market
The global Alzheimer’s Disease Therapeutics and Diagnostics market size is projected to reach US$ 8589.1 million by 2026, from US$ 6596.5 million in 2019, at a CAGR of 3.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alzheimer’s Disease Therapeutics and Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alzheimer’s Disease Therapeutics and Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alzheimer’s Disease Therapeutics and Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alzheimer’s Disease Therapeutics and Diagnostics market.

Global Alzheimer’s Disease Therapeutics and Diagnostics Scope and Market Size
Alzheimer’s Disease Therapeutics and Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer’s Disease Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Lumbar puncture test
Computed tomography (CT) scan
Magnetic resonance imaging (MRI)
Electroencephalography (EEG)
Positron emission tomography (PET) scan
Others

Segment by Application
Marketed Drugs
Pipeline Drugs

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Eisai
Novartis
Forest Laboratories
TauRx Therapeutics
AC Immune
Johnson & Johnson.
H. Lundbeck

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lumbar puncture test
1.2.3 Computed tomography (CT) scan
1.2.4 Magnetic resonance imaging (MRI)
1.2.5 Electroencephalography (EEG)
1.2.6 Positron emission tomography (PET) scan
1.2.7 Others
1.3 Market by Application
1.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Marketed Drugs
1.3.3 Pipeline Drugs
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Perspective (2016-2027)
2.2 Alzheimer’s Disease Therapeutics and Diagnostics Growth Trends by Regions
2.2.1 Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Alzheimer’s Disease Therapeutics and Diagnostics Industry Dynamic
2.3.1 Alzheimer’s Disease Therapeutics and Diagnostics Market Trends
2.3.2 Alzheimer’s Disease Therapeutics and Diagnostics Market Drivers
2.3.3 Alzheimer’s Disease Therapeutics and Diagnostics Market Challenges
2.3.4 Alzheimer’s Disease Therapeutics and Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alzheimer’s Disease Therapeutics and Diagnostics Revenue
3.4 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Therapeutics and Diagnostics Revenue in 2020
3.5 Alzheimer’s Disease Therapeutics and Diagnostics Key Players Head office and Area Served
3.6 Key Players Alzheimer’s Disease Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2022-2027)

5 Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2016-2027)
6.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type
6.2.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2027)
6.3 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application
6.3.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2027)
6.4 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country
6.4.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2016-2027)
7.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type
7.2.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2027)
7.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application
7.3.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2027)
7.4 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country
7.4.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type
8.2.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application
8.3.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region
8.4.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2016-2027)
9.2 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type
9.2.1 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application
9.3.1 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country
9.4.1 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type
10.2.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application
10.3.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country
10.4.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.1.4 Pfizer Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.2.4 Eisai Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
11.2.5 Eisai Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.3.4 Novartis Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Forest Laboratories
11.4.1 Forest Laboratories Company Details
11.4.2 Forest Laboratories Business Overview
11.4.3 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.4.4 Forest Laboratories Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
11.4.5 Forest Laboratories Recent Development
11.5 TauRx Therapeutics
11.5.1 TauRx Therapeutics Company Details
11.5.2 TauRx Therapeutics Business Overview
11.5.3 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.5.4 TauRx Therapeutics Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
11.5.5 TauRx Therapeutics Recent Development
11.6 AC Immune
11.6.1 AC Immune Company Details
11.6.2 AC Immune Business Overview
11.6.3 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.6.4 AC Immune Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
11.6.5 AC Immune Recent Development
11.7 Johnson & Johnson.
11.7.1 Johnson & Johnson. Company Details
11.7.2 Johnson & Johnson. Business Overview
11.7.3 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.7.4 Johnson & Johnson. Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
11.7.5 Johnson & Johnson. Recent Development
11.8 H. Lundbeck
11.8.1 H. Lundbeck Company Details
11.8.2 H. Lundbeck Business Overview
11.8.3 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.8.4 H. Lundbeck Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
11.8.5 H. Lundbeck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Lumbar puncture test
Table 3. Key Players of Computed tomography (CT) scan
Table 4. Key Players of Magnetic resonance imaging (MRI)
Table 5. Key Players of Electroencephalography (EEG)
Table 6. Key Players of Positron emission tomography (PET) scan
Table 7. Key Players of Others
Table 8. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Regions (2016-2021)
Table 12. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Regions (2022-2027)
Table 14. Alzheimer’s Disease Therapeutics and Diagnostics Market Trends
Table 15. Alzheimer’s Disease Therapeutics and Diagnostics Market Drivers
Table 16. Alzheimer’s Disease Therapeutics and Diagnostics Market Challenges
Table 17. Alzheimer’s Disease Therapeutics and Diagnostics Market Restraints
Table 18. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Players (2016-2021)
Table 20. Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer’s Disease Therapeutics and Diagnostics as of 2020)
Table 21. Ranking of Global Top Alzheimer’s Disease Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Alzheimer’s Disease Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Alzheimer’s Disease Therapeutics and Diagnostics Product Solution and Service
Table 25. Date of Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type (2016-2021)
Table 29. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Application (2016-2021)
Table 33. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 68. Pfizer Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Eisai Company Details
Table 71. Eisai Business Overview
Table 72. Eisai Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 73. Eisai Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 74. Eisai Recent Development
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 78. Novartis Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 79. Novartis Recent Development
Table 80. Forest Laboratories Company Details
Table 81. Forest Laboratories Business Overview
Table 82. Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 83. Forest Laboratories Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 84. Forest Laboratories Recent Development
Table 85. TauRx Therapeutics Company Details
Table 86. TauRx Therapeutics Business Overview
Table 87. TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 88. TauRx Therapeutics Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 89. TauRx Therapeutics Recent Development
Table 90. AC Immune Company Details
Table 91. AC Immune Business Overview
Table 92. AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 93. AC Immune Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 94. AC Immune Recent Development
Table 95. Johnson & Johnson. Company Details
Table 96. Johnson & Johnson. Business Overview
Table 97. Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 98. Johnson & Johnson. Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Johnson & Johnson. Recent Development
Table 100. H. Lundbeck Company Details
Table 101. H. Lundbeck Business Overview
Table 102. H. Lundbeck Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 103. H. Lundbeck Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Lumbar puncture test Features
Figure 3. Computed tomography (CT) scan Features
Figure 4. Magnetic resonance imaging (MRI) Features
Figure 5. Electroencephalography (EEG) Features
Figure 6. Positron emission tomography (PET) scan Features
Figure 7. Others Features
Figure 8. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application: 2020 VS 2027
Figure 9. Marketed Drugs Case Studies
Figure 10. Pipeline Drugs Case Studies
Figure 11. Alzheimer’s Disease Therapeutics and Diagnostics Report Years Considered
Figure 12. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Regions: 2020 VS 2027
Figure 15. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Regions (2022-2027)
Figure 16. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Players in 2020
Figure 17. Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer’s Disease Therapeutics and Diagnostics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Alzheimer’s Disease Therapeutics and Diagnostics Revenue in 2020
Figure 19. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type (2016-2021)
Figure 20. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type (2022-2027)
Figure 21. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 23. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 24. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 25. United States Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 29. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 30. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 31. Germany Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region (2016-2027)
Figure 41. China Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 49. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 50. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 51. Mexico Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 57. Turkey Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
Figure 61. Eisai Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
Figure 63. Forest Laboratories Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
Figure 64. TauRx Therapeutics Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
Figure 65. AC Immune Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
Figure 66. Johnson & Johnson. Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
Figure 67. H. Lundbeck Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---